Synthetic Peptide Modulators of Staphylococcus Epidermidis Quorum Sensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Staphylococcus epidermidis infections, particularly those related to medical devices, are challenging due to its ability to form biofilms and develop resistance to antibiotics, with the agr quorum sensing system playing a complex role in virulence and biofilm formation, necessitating effective modulators to control its virulence.
Innovation Solution
Development of synthetic agonists and antagonists that target the AgrC quorum sensing system of S. epidermidis, including specific AIP-I analogs that selectively modulate the agr system, offering potent inhibition of biofilm growth and potential species-specific targeting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antibiotics are used to treat S. epidermidis infections, then bacterial growth is inhibited, but resistance development occurs and treatment effectiveness is reduced
Solution Approach 1:
The patent converts the harmful agr system, which promotes virulence and biofilm formation, into a beneficial target for inhibition. By designing small molecules that specifically inhibit AgrC kinase activity, the patent transforms the pathogen's own virulence mechanism into a vulnerability that can be exploited for treatment, thereby overcoming antibiotic resistance without selecting for further resistance
Solution Approach 2:
The patent introduces small molecule inhibitors as intermediaries that mediate between the external treatment environment and the bacterial agr system. These molecules act as mediators that specifically bind to and inhibit AgrC, thereby indirectly controlling virulence and biofilm formation without directly killing bacteria, thus avoiding the selection pressure that leads to resistance
2Reliability
If agr system is activated to reduce biofilm growth, then biofilm formation is limited, but virulence control becomes complex due to multiple roles of agr system
Solution Approach 1:
Instead of activating the agr system to reduce biofilm (as previously attempted), the patent inverts the approach by specifically inhibiting AgrC kinase activity. This inversion allows for precise control of the agr system's output without triggering the complex feedback loops and unintended consequences associated with activation, thereby simplifying virulence control while effectively reducing biofilm formation
Solution Approach 2:
The patent changes the parameter of agr system control from activation (increasing activity) to inhibition (decreasing activity). By using small molecules that specifically inhibit AgrC kinase activity, the patent achieves precise parameter control over virulence factor expression and biofilm formation, avoiding the complexity associated with system-wide activation
3Productivity
If broad-spectrum antibiotics are used to treat infections, then multiple pathogens are targeted, but S. epidermidis resistance and recalcitrance increase
Solution Approach 1:
The patent applies local quality by designing inhibitors with high specificity for the staphylococcal agr system, particularly AgrC kinase. The small molecules are structurally optimized to interact specifically with conserved residues in the ATP-binding pocket of AgrC, ensuring localized and precise inhibition of staphylococcal virulence without affecting other bacterial systems or promoting broad resistance
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These modulators effectively inhibit S. epidermidis biofilm growth and virulence, providing tools for treating infections and elucidating the role of the agr system, with some analogs showing pan-group or group-selective inhibition and species-specific activity.
Implementation Method 1
QS is a cell-cell communication process that allows bacteria to sense population density and coordinate gene expression to control group behavior at high cell numbers
Implementation Method 2
Productive binding of the AIP to AgrC, a transmembrane receptor histidine kinase, triggers its subsequent dimerization and trans-autophosphorylation
Implementation Method 3
Phosphorylated AgrA next dimerizes, binds the P2 and P3 promoters, and upregulates the transcription of the agr locus and RNAIII, respectively
Implementation Method 4
Phosphorylated AgrA also directly activates the production of a group of small amphipathic peptides known as phenol-soluble modulins (PSMs), which are key virulence factors for both the biofilm life cycle and survival in infected hosts
Implementation Method 5
the agr system negatively regulates the expression of the surface-attached AtlE protein, an important adhesion factor in the attachment phase of biofilm growth
Implementation Method 6
positively regulates the production of PSMs and proteases that facilitate the detachment of bacteria from biofilm
Data Source
AI summary
Synthetic cyclic peptide modulators of the AgrC quorum sensing system of S. epidermidis. Synthetic agonists and antagonist of AgrC-I are described. Compounds capable of either pan-group or group-selective AgrC receptor inhibition in S. epidermidis were identified. Additionally, compounds that are species selective, and could be applied to selectively modulate either S. epidermidis or S. aureus AgrC receptors were identified. An AgrC-I agonist was found which strongly inhibits S. epidermidis biofilm growth, with a higher potency and efficacy than that of native AIP-I. Methods of modulating virulence in S. epidermidis and related Staphylococcus by contacting a bacterium or a bacterial environment, such as a biofilm, with a modulator of the disclosure are provided. Methods are provided for treating infections of S. epidermidis and related Staphylococcus by administering a therapeutically effective amount of one or more compounds herein to an individual in need thereof.